Investigation of bone health subsequent to Vitamin D supplementation in children following burn injury

Nutrition in Clinical Practice

Volumn 30, Issue 6, 2015, Pages 830-837

  Mayes, Theresa ^a,b   Gottschlich, Michele M ^a,c   Khoury, Jane ^b   Kagan, Richard J ^a,c  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

bone density; bone fractures; bone health; burns; pediatrics; Vitamin D; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCITONIN; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; VITAMIN; VITAMIN D;

ADOLESCENT; ARTICLE; BONE; BONE DEMINERALIZATION; BONE DENSITY; BURN; CALCITONIN BLOOD LEVEL; CALCIUM URINE LEVEL; CHILD; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION; BURNS; CAUSALITY; DIETARY SUPPLEMENT; DRUG EFFECTS; FOLLOW UP; FRACTURES, BONE; PHOTON ABSORPTIOMETRY; PRESCHOOL CHILD;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BONE DENSITY; BURNS; CAUSALITY; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HUMANS; INFANT; MALE; VITAMIN D; VITAMINS;

EID: 84946709004     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533615587720     Document Type: Article

References (91)

1. Klein GL, Herndon DN, Langman CB, et al. Long-term reduction in bone mass after severe burn injury in children. J Pediatr. 1995; 126: 252-256.
2. Klein GL, Herndon DN, Goodman WG, et al. Histomorphometric and biochemical characterization of bone following acute severe burns in children. Bone. 1995; 17: 455-460.
3. Klein GL, Herndon DN, Rutan TC, et al. Bone disease in burn patients. J Bone Miner Res. 1993; 8: 337-345.
4. Klein GL, Wolf SE, Goodman WG, et al. The management of acute bone loss in severe catabolism due to burn injury. Horm Res. 1997; 5: 83-87.
5. Leblebici B, Sezgin N, Ulusan SN, et al. Bone loss during the acute stage following burn injury. J Burn Care Res. 2008; 29: 763-770.
6. Edelman LS, McNaught T, Chan GM, et al. Sustained bone mineral density changes after burn injury. J Surg Res. 2003; 114: 172-178.
7. Przkora R, Barrow RE, Jeschke MG, et al. Body composition changes with time in pediatric burn patients. J Trauma Injury Infect Crit Care. 2006; 60: 968-971.
8. Dolecek R, Tymonova J, Adamkova M, et al. Endocrine changes after burns: the bone involvement. Acta Chir Plast. 2003; 45: 95-103.
9. Klein GL,. Burn-induced bone loss: importance, mechanisms, and management. J Burns Wounds. 2006; 5: e5.
10. Mayes T, Gottschlich M, Scanlon J, et al. Four-year review of burns as an etiologic factor in the development of long bone fractures in pediatric patients. J Burn Care Rehabil. 2003; 5: 279-284.
11. English C, Carmichael KD,. Management of fractures in children with thermal injuries. J. Pediatr Orthoped. 2002; 22: 725-728.
12. Gottschlich MM, Mayes T, Khoury J, et al. Hypovitaminosis D in acutely injured pediatric burn patients. J Am Diet Assoc. 2004; 104: 931-941.
13. Klein GL, Langman CB, Herndon DN,. Vitamin D depletion following burns in children: a possible factor in post-burn osteopenia. J Trauma. 2002; 52: 346-350.
14. Gottschlich MM, Mayes T, Khoury J, Kagan R,. Clinical trial of vitamin D2 versus D3 supplementation in critically ill pediatric burn patients. [published online ahead of print 9, 2015 ]. JPEN J Parenter Enteral Nutr. doi: 10.1177/0148607115587948.
15. Mitsuhashi T, Morris RC, Ives HE,. 1,25 Dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest. 1991; 87: 1889-1895.
16. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharm. 1991; 42: 1569-1575.
17. Schwartz Z, Bonewald LF, Caulfield K, et al. Direct effects of transforming growth factor-beta on chondrocytes are modulated by vitamin D metabolites in a cell maturation-specific manner. Endocrinology. 1993; 132: 1544-1552.
18. Pfeifer M, Begerow B, Minne HW,. Vitamin D and muscle function. Osteoporos Int. 2002; 13: 187-194.
19. Dhesi JK, Jackson S, Bearne LM, et al. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Aging. 2004; 33: 589-595.
20. Dhesi JK, Bearne LM, Moniz C, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res. 2002; 17: 891-897.
21. Shinchuk LM, Holick MF,. Vitamin D and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007; 22: 297-304.
22. Nimitphong H, Holick MF,. Vitamin D, neurocognitive functioning and immunocompetence. Curr Opin Clin Nutr Metab Care. 2011; 14: 7-14.
23. Hewison M,. Vitamin D and the immune system: new perspectives on an old theme. Rheum Dis Clin North Am. 2012; 38: 125-139.
24. Hewison M,. Vitamin D and innate and adaptive immunity. Vitam Horm. 2011; 86: 23-62.
25. Bikle DD,. Vitamin D regulation of immune function. Vitam Horm. 2011; 86: 1-21.
26. Shab-Bidar S, Neyestani TR, Djazayery A, et al. Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab Res Rev. 2012; 28 (5): 424-430.
27. Chagas CE, Borges MC, Martini LA, et al. Focus on vitamin D, inflammation and type 2 diabetes. Nutrients. 2012; 4: 52-67.
28. Stivelman E, Retnakaran R,. Role of vitamin D in the pathophysiology and treatment of type 2 diabetes. Curr Diabetes Rev. 2012; 8: 42-47.
29. Alvarez JA, Ashraf A,. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010; 2010: 351385.
30. Forouhi NG, Luan J, Cooper A, et al. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study. 1990-2000. Diabetes. 2008; 57: 2619-2625.
31. Gonzalez PV, Boland R, Russo de Boland A,. Vitamin D and cancer: antineoplastic effects of 1 alpha 25 (OH)-vitamin D. Medicine. 2012; 72: 143-149.
32. Hansen CM, Binderup L, Hamberg KJ, Carlberg C,. Vitamin D and cancer: effects of 1,25 (OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci. 2001; 6: D820-D848.
33. Chen TC, Holick MF, Lokeshwar BL, et al. Evaluation of vitamin D analogs as therapeutic agents for prostate cancer. Recent Results Cancer Res. 2003; 164: 273-288.
34. Krishnan AV, Trump DL, Johnson CS, et al. The role of vitamin D in cancer prevention and treatment. Rheum Dis Clin North Am. 2012; 38: 161-178.
35. Slominski A, Janjetovic Z, Kim TK, et al. Novel vitamin D hydroxy derivatives inhibit melanoma growth and show differential effects on normal melanocytes. Anticancer Res. 2012; 32: 3733-3742.
36. Ascherio A, Munger K, Simon K,. Vitamin D and multiple sclerosis. Lancet Neurol. 2010; 9: 599-612.
37. Smolders J, Menheere P, Kessels A, et al. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Multiple Sclerosis. 2008; 14: 1220-1224.
38. Burton J, Kimball S, Vieth R, et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology. 2010; 74: 1852-1859.
39. Pierrot-Deseilligny C,. Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol. 2009; 256: 1468-1479.
40. Mowry EM, Krupp LB, Milazzo M, et al. Vitamin D is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol. 2010; 67: 618-624.
41. Turner AG, Anderson PH, Morris HA,. Vitamin D and bone health. Scand J Clin Lab Invest Suppl. 2012; 243: 65-72.
42. Anderson PH, Turner AG, Morris HA,. Vitamin D actions to regulate calcium and skeletal homeostasis. Clin Biochem. 2012; 45 (12): 880-886.
43. Bikle DD,. Vitamin D and bone. Curr Osteoporos Rep. 2012; 10 (2): 151-159.
44. Berry JL, Davies M, Mee AP,. Vitamin D metabolism, rickets, and osteomalacia. Semin Musculoskelet Radiol. 2002; 6: 173-182.
45. Bhan A, Rao AD, Rao DS,. Osteomalacia as a result of vitamin D deficiency. Endocrinol Metab Clin North Am. 2010; 39: 321-331.
46. Donaldson CL, Hulley SB, Vogel JM, et al. Effect of prolonged bed rest on bone mineral. Metabolism. 1970; 19: 1071-1084.
47. Nishimura Y, Fukuoka H, Kiriyama M, et al. Bone turnover and calcium metabolism during 20 days bed rest in young healthy males and females. Acta Physiol Scand. 1994; 616: 27-35.
48. Whedon GD,. Disuse osteoporosis: physiological aspects. Calcified Tissue Int. 1984; 36: S146-S150.
49. Minaire P,. Immobilization osteoporosis: a review. Clin Rheum. 1989; 8: 95-103.
50. Klein GL, Bi Lin Xiang, Sherrard DJ, et al. Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int. 2004; 15: 468-474.
51. Hart DW, Herndon DN, Klein G, et al. Attenuation of post-traumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg. 2001; 233: 827-834.
52. Klein GL, Wolf SE, Langman CB, et al. Effect of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab. 1998; 83: 21-24.
53. Wray CJ, Mayes T, Khoury J, et al. Metabolic effects of vitamin D on serum calcium, magnesium, and phosphorus in pediatric burn patients. J Burn Care Rehabil. 2002; 23: 416-423.
54. Norman AW,. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr. 1998; 67: 1108-1110.
55. Gottschlich MM, Jenkins M, Warden GD, et al. Differential effects of three enteral regimens on selected outcome parameters. JPEN J Parenter Enteral Nutr. 1990; 14: 225-236.
56. Gottschlich MM, Alexander JW,. Fat kinetics and recommended dietary intake in burns. JPEN J Parenter Enteral Nutr. 1987; 11: 80-85.
57. Bikle DD, Gee E, Halloran B, et al. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986; 63: 954-959.
58. Klein GL, Herndon DN,. Magnesium deficit in major burns: role in hypoparathyroidism and end-organ parathyroid hormone resistance. Magnes Res. 1998; 11: 103-109.
59. Klein GL, Langman CB, Herndon DN,. Persistent hypoparathyroidism following magnesium repletion in burn-injured children. Pediatr Nephrol. 2000; 14: 301-304.
60. Murphey ED, Chattopadhyay N, Bai M, et al. Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: a potential contributory factor to postburn hypocalcemia. Crit Care Med. 2000; 28: 3885-3890.
61. Hart DW, Wolf SE, Micak R, et al. Persistence of muscle catabolism after severe burn. Surgery. 2000; 128: 312-319.
62. Klein GL, Chen TC, Holick MF, et al. Synthesis of vitamin D in skin after burns. Lancet. 2004; 363: 291-292.
63. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2010.
64. Landin LA,. Fracture epidemiology. In: Benson M, Fixsen J, Macnicol M, Parsch K, eds. Children's Orthopedics and Fractures. 3rd ed. New York, NY: Springer Verlag; 2010: 665-670.
65. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation. JAMA. 2005; 293: 2257-2263.
66. Abrahamsen B,. Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in US and Europe. BMJ. 2010; 3460: b5463.
67. Reginster JY,. Effect of calcitonin on bone mass and fracture rates. Am J Med. 1991; 91: 19S-22S.
68. Munoz-Torres M, Alonso G, Raya PM,. Calcitonin therapy in osteoporosis. Treat Endocrinol. 2004; 3: 117-132.
69. Cranney A, Welch V, Adachi JD, et al. Calcitonin for preventing and treating corticosteroid-induced osteoporosis. Cochrane Database Syst Rev. 2000;(1): CD001983.
70. Akcay MN, Akcay G, Yilmaz I,. The effect of calcitonin and growth hormone on urinary deoxypyridinoline levels in burned patients. Burns. 2002; 28 (4): 311-313.
71. Miyamoto KK, McSherry SA, Robins SP, Besterman JM, Mohler JL,. Collagen cross-link metabolites in urine as markers of bone metastases in prostatic carcinoma. J Urol. 1994; 151: 909-913.
72. Nemoto R, Nakamura I, Nishijama Y, et al. Serum pyridinoline cross-links as markers of tumor-induced bone resorption. Br J Urol. 1997; 80: 274-280.
73. Gottschlich MM, Mayes T, Allgeier C, Khoury J, Kagan RJ,. Calcitonin status in children following recovery from acute burn injury. J Burn Care Rehabil. 2005; 26: S143.
74. Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA,. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int. 2000; 11: 76-82.
75. Garnero P, Sornay-Rendu E, Claustrat B, Delmas P,. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000; 15: 1526-1536.
76. Kress BC, Mizrahi IA, Armour KW, Marcus R, Emkey RD, Santora AC,. Use of bone alkaline phosphates to monitor alendronate therapy in individual postmenopausal osteoporotic women. Clin Chem. 1999; 45: 1009-1017.
77. 3 inhibits neutrophil recruitment in hamster model of acute long injury. Steroids. 2011; 76: 1305-1309.
78. Zosky GR, Berry LJ, Elliott G, et al. Vitamin D deficiency causes deficits in lung function and alters lung structure. J Respir Crit Care Med. 2011; 183: 1336-1343.
79. Specker B, Schoenau E,. Quantitative bone analysis in children: current methods and recommendations. J Pediatr. 2005; 146: 726-731.
80. Huang C, Ross P, Wasnich RD,. Short-term and long-term fracture prediction by bone mass measurements: a prospective study. J Bone Miner Res. 1998; 13: 107-113.
81. Cummings SR, Black DM, Nevitt MC, et al. The study of osteoporotic fractures research group: bone densitometry at various sites for prediction of hip fractures. Lancet. 1993; 341: 72-75.
82. Gafni R, Baron J,. Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA). J Pediatr. 2004; 144: 253-257.
83. Dao D, Sodhi S, Tabasinejad R, et al. Serum 25-hydroxyvitamin D levels and stress fractures in military personnel. [published online November 4, 2014]. Am J Sports Med.
84. Harrison L,. Lower stress fracture risk in girls linked to vitamin D intake. Arch Pediatr Adolesc Med. 2012; 166: 595-600.
85. Pieper CF, Colon-Emeric C, Caminis J, et al. Distribution and correlates of serum 25-hydroxyvitamin D levels in a sample of patients with hip fracture. Am J Geriatr Pharmacother. 2007; 5: 335-340.
86. Bischoff-Ferrari HA, Can U, Staehelin HB, et al. Severe vitamin D deficiency in Swiss hip fracture patients. Bone. 2008; 42: 597-602.
87. LeBoff MS, Kohlmeier L, Hurwitz S, et al. Occult vitamin D deficiency in postmenopausal U.S. women with acute hip fracture. JAMA. 1999; 281: 1505-1511.
88. Gallacher SJ, McQuillian C, Harkness M, et al. Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures. Curr Med Res Opin. 2005; 21: 1355-1361.
89. Moniz C, Dew T, Dixon T,. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin. 2005; 21: 1891-1894.
90. Looker AC, Mussolino ME,. Serum 25-hydroxyvitamin D and hip fracture risk in older U.S. white adults. J Bone Miner Res. 2008; 23: 143-150.
91. Isenor JE, Ensom MH,. Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk? Pharmacotherapy. 2010; 30: 254-264.